Pharmaceuticals
-
New enzyme target for neuroblastoma
Scientists have identified a possible new treatment for neuroblastoma in children. Read more
-
Monkeypox guidelines lacking globally
There is a lack of reliable guidelines for monkeypox available around the world, experts warn today. Read more
-
Rise in intravenous nutrition use among athletes
Elite sport players in European and America are increasingly turning to intravenous nutrition products, experts warn today. Read more
-
UK approves the first bivalent COVID-19 booster vaccine
A bivalent COVID-19 vaccine, targeting the original strain and the Omicron variant, has been approved for use in the UK for the first time. Read more
-
Serotonin link to depression debunked
Depression may not be linked to serotonin levels or serotonin activity, according to a major study published yesterday. Read more
-
COVID vaccines prevented some patient-facing healthcare workers getting infected
The COVID-19 vaccine rollout averted infection in 10% of NHS patient-facing healthcare staff during the second wave of the pandemic, new research shows today. Read more
-
Two new drugs offer insomnia hope
Two drugs that are not licensed to treat insomnia performed well in adults with acute and long-term condition, researchers report today. Read more
-
Second COVID booster advised for certain groups
A second COVID-19 vaccine booster shot is being recommended for ‘moderately and severely immunocompromised’ people from five years of age. Read more
-
How vaccines might curb antimicrobial resistance
There is progress in developing vaccines to prevent infections caused by antimicrobial-resistant bacteria, according to a major new analysis. Read more
-
Hyaluronic acid may not benefit knee osteoarthritis
Injecting hyaluronic acid should no longer be recommended as a treatment for knee osteoarthritis because there is no evidence that it benefits patients, according to an analysis published today. Read more
